The page of GLS. Captures the information on Price and Volume for the stock. It also contains the Live Stock Price and Volume, 52 Week High Low and Volume data.Intradaystock prediction for today 21-01-2025 is predicted based on technical analysis and should only be used as reference for learning purpose only.
| Company Name | Price | Change | % Chg | Day High | Day Low | Previous Close | Volume |
|---|---|---|---|---|---|---|---|
| Morepen Lab | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Marksans Pharma | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kopran | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sequent Scienti | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Alivus Life Sciences Limited engages in the development, manufacture, and marketing of non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers various APIs, such as olmesartan, telmisartan, perindopril, atovaquone, solifenacin, mirabegron, sitagliptin, zonisamide, adapalene, and rosuvastatin. It also provides contract development and manufacturing services to a range of multinational corporations and specialty companies. The company's APIs are used in various therapeutic segments, including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, and anti-infectives. It also exports its products to Europe, North America, Latin America, Japan, and internationally. The company was formerly known as Glenmark Life Sciences Limited and changed its name to Alivus Life Sciences Limited in December 2024. The company was incorporated in 2011 and is based in Mumbai, India. Alivus Life Sciences Limited is a subsidiary of Nirma Limited.
| Company | LTP | Change | Gain |
|---|---|---|---|
| Kotak-Mahindra-Bank-Limited | 1920.5 | 161.9 | 9.21 % |
| Wipro | 300.25 | 18.3 | 6.49 % |
| Company | LTP | Change | Loss |
|---|---|---|---|
| Tata-Consultancy-Services-Limited | 4077.8 | -46.5 | -1.13 % |
| Maruti-Suzuki | 12020.0498 | -116.3 | -0.96 % |
